Enzymatic sulfation of mucin in gastric mucosa: effect of sofalcone, sucralfate and aspirin. 1987

B L Slomiany, and Y H Liau, and S R Carter, and J Sarosiek, and H Tsukada, and A Slomiany
Department of Medicine, New York Medical College, Valhalla.

A sulfotransferase activity which catalyzes the transfer of a sulfate group from 3'-phosphoadenosine-5'-phosphosulfate to gastric mucus glycoprotein has been demonstrated in the rat gastric mucosa. Subcellular fractionation studies revealed that the enzyme activity was present in a Golgi-rich membrane fraction. Optimum enzymatic activity for sulfation of mucus glycoprotein was obtained with 0.5% Triton X-100 and 30 mM NaF at a pH of 6.8. The apparent Km of the enzyme for gastric mucus glycoprotein was 10.5 microM, and the sulfate ester was found incorporated into the carbohydrate chains of mucin. The sulfo-transferase activity of the Golgi enzyme was stimulated by sofalcone, while reduction in the rate of sulfation occurred in the presence of sucralfate and aspirin. The rate of enhancement of mucin sulfation by sofalcone was proportional to the drug concentration up to 5 X 10(-7) M, at which concentration a 17% increase in the glycoprotein sulfation was attained. The rate of inhibition of mucin sulfation was proportional to concentrations of aspirin up to 3 X 10(-4) M and of sucralfate up to 1 X 10(-4) M, at which concentrations about 50% reduction in sulfotransferase activity was obtained. The apparent KI values calculated from the double-reciprocal plots were 15.1 microM for aspirin and 19.6 microM for sucralfate. The results suggest that although both sucralfate and sofalcone are potent gastric mucosal strengthening agents, only sofalcone is capable of enhancement of the sulfotransferase enzyme involved in gastric mucin sulfation.

UI MeSH Term Description Entries
D008297 Male Males
D009077 Mucins High molecular weight mucoproteins that protect the surface of EPITHELIAL CELLS by providing a barrier to particulate matter and microorganisms. Membrane-anchored mucins may have additional roles concerned with protein interactions at the cell surface. Mucin
D011427 Propiophenones Propiophenone (ethyl phenyl ketone, structural formula C6H5COCH2CH3) and its derivatives. They are commonly used in perfumes and pharmaceuticals.
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D002599 Chalcone An aromatic KETONE that forms the core molecule of CHALCONES. Benzalacetophenone,Benzylideneacetophenone,1,3-Diphenyl-2-Propen-1-One,Chalkone,1,3 Diphenyl 2 Propen 1 One
D005753 Gastric Mucosa Lining of the STOMACH, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. The surface cells produce MUCUS that protects the stomach from attack by digestive acid and enzymes. When the epithelium invaginates into the LAMINA PROPRIA at various region of the stomach (CARDIA; GASTRIC FUNDUS; and PYLORUS), different tubular gastric glands are formed. These glands consist of cells that secrete mucus, enzymes, HYDROCHLORIC ACID, or hormones. Cardiac Glands,Gastric Glands,Pyloric Glands,Cardiac Gland,Gastric Gland,Gastric Mucosas,Gland, Cardiac,Gland, Gastric,Gland, Pyloric,Glands, Cardiac,Glands, Gastric,Glands, Pyloric,Mucosa, Gastric,Mucosas, Gastric,Pyloric Gland
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000897 Anti-Ulcer Agents Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. Anti-Ulcer Drugs,Agents, Anti-Ulcer,Anti Ulcer Agents,Anti Ulcer Drugs,Drugs, Anti-Ulcer
D001241 Aspirin The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) Acetylsalicylic Acid,2-(Acetyloxy)benzoic Acid,Acetysal,Acylpyrin,Aloxiprimum,Colfarit,Dispril,Easprin,Ecotrin,Endosprin,Magnecyl,Micristin,Polopirin,Polopiryna,Solprin,Solupsan,Zorprin,Acid, Acetylsalicylic

Related Publications

B L Slomiany, and Y H Liau, and S R Carter, and J Sarosiek, and H Tsukada, and A Slomiany
August 1990, Biochemical and biophysical research communications,
B L Slomiany, and Y H Liau, and S R Carter, and J Sarosiek, and H Tsukada, and A Slomiany
December 1980, Steroids,
B L Slomiany, and Y H Liau, and S R Carter, and J Sarosiek, and H Tsukada, and A Slomiany
September 1988, Biochemical pharmacology,
B L Slomiany, and Y H Liau, and S R Carter, and J Sarosiek, and H Tsukada, and A Slomiany
January 1985, Arzneimittel-Forschung,
B L Slomiany, and Y H Liau, and S R Carter, and J Sarosiek, and H Tsukada, and A Slomiany
September 1987, The American journal of medicine,
B L Slomiany, and Y H Liau, and S R Carter, and J Sarosiek, and H Tsukada, and A Slomiany
January 1981, Journal of clinical gastroenterology,
B L Slomiany, and Y H Liau, and S R Carter, and J Sarosiek, and H Tsukada, and A Slomiany
July 1987, Research communications in chemical pathology and pharmacology,
B L Slomiany, and Y H Liau, and S R Carter, and J Sarosiek, and H Tsukada, and A Slomiany
September 1992, The American journal of gastroenterology,
B L Slomiany, and Y H Liau, and S R Carter, and J Sarosiek, and H Tsukada, and A Slomiany
June 1966, Gut,
B L Slomiany, and Y H Liau, and S R Carter, and J Sarosiek, and H Tsukada, and A Slomiany
January 1981, Journal of clinical gastroenterology,
Copied contents to your clipboard!